{
  "@context": {
    "dcterms": "http://purl.org/dc/terms/",
    "cito": "http://purl.org/spar/cito/",
    "deo": "http://purl.org/spar/deo/"
  },
  "@id": "https://hypothesis.bioagent.ai/ac72tuthsl4",
  "@type": "deo:FutureWork",
  "cito:usesDataFrom": [
    "https://doi.org/10.1186/s13041-024-01028-8",
    "https://doi.org/10.1002/dad2.12391",
    "https://doi.org/10.1234/62408"
  ],
  "dcterms:references": [
    "# Mechanistic Hypothesis Connecting DOPAL's Anti-Oligomerization Effect and Neprilysin's Aβ Degradation\n\n## 1. Background\nDOPAL (3,4-dihydroxyphenylacetaldehyde), a reactive aldehyde produced during dopamine metabolism by monoamine oxidase (MAO), decreases Aβ oligomerization in human neuroblastoma cells, reducing Aβ cytotoxicity through mechanisms that remain incompletely understood. Neprilysin (NEP) functions as a key Aβ-degrading enzyme that primarily targets monomeric Aβ forms for proteolytic clearance, with expression levels that decline during aging and Alzheimer's disease progression. As evidenced in Abstract 1, L-DOPA administration significantly reduces Aβ plaque burden in 5xFAD mice specifically by upregulating NEP levels, suggesting a potential mechanistic linkage between dopamine metabolism and Aβ clearance pathways.\n\n## 2. Knowledge Gap\nWhile DOPAL's anti-oligomerization effects and neprilysin's Aβ-degrading functions have been separately studied, the potential molecular crosstalk between these two processes remains unexplored. Specifically, it is unknown whether DOPAL might exert its protective effects not only by directly inhibiting Aβ aggregation but also by enhancing neprilysin-mediated clearance through shared redox-sensitive regulatory pathways.\n\n## 3. Central Hypothesis\nDOPAL promotes a redox-dependent post-translational modification of neprilysin that enhances its catalytic activity specifically toward monomeric Aβ, while simultaneously preventing Aβ oligomerization through direct binding, thereby creating a synergistic dual mechanism for Aβ clearance.\n\n## 4. Proposed Mechanism\n1. DOPAL, produced via MAO-catalyzed oxidation of dopamine, binds to specific lysine residues on monomeric Aβ peptides via Schiff base formation, creating DOPAL-Aβ adducts that sterically hinder β-sheet formation necessary for oligomerization.\n\n2. Simultaneously, DOPAL's reactive aldehyde group interacts with critical cysteine residues in neprilysin's non-catalytic regulatory domains, inducing conformational changes that enhance the enzyme's substrate accessibility and catalytic efficiency specifically toward monomeric Aβ.\n\n3. This DOPAL-mediated post-translational modification of neprilysin activates the enzyme through an allosteric mechanism that increases its affinity for Aβ monomers without affecting its overall expression levels.\n\n4. The DOPAL-modified neprilysin preferentially cleaves monomeric Aβ at specific sites, generating fragments that are less prone to aggregation and more easily cleared by microglial phagocytosis and glymphatic drainage.\n\n5. L-DOPA administration amplifies this pathway by increasing both DOPAL production and neprilysin expression (as shown in Abstract 1), creating a feed-forward mechanism that simultaneously prevents oligomerization and enhances degradation of monomeric Aβ.\n\n## 5. Testable Predictions\n1. Treatment of purified neprilysin with physiological concentrations of DOPAL should increase its enzymatic activity toward Aβ peptides in vitro, an effect that would be abolished by pre-treating DOPAL with carbonyl-trapping agents or by mutating specific cysteine residues in neprilysin's regulatory domains.\n\n2. In neuroblastoma cells expressing fluorescently-tagged neprilysin, DOPAL treatment should induce measurable conformational changes in the enzyme (detectable by FRET or other biophysical approaches) that correlate with enhanced Aβ degradation rates.\n\n3. Cerebrospinal fluid from Parkinson's disease patients treated with L-DOPA should contain neprilysin with higher catalytic activity toward Aβ compared to control samples, and this enhanced activity should correlate positively with DOPAL levels and negatively with oligomeric Aβ species.\n\n## 6. Potential Experimental Approaches\n1. Develop a mass spectrometry-based approach to identify specific DOPAL-modified residues on neprilysin isolated from L-DOPA-treated neuronal cultures or mouse brain tissue. Compare the enzymatic activity of native versus DOPAL-modified neprilysin against synthetic Aβ substrates using kinetic assays, while monitoring structural changes using hydrogen-deuterium exchange mass spectrometry.\n\n2. Generate a transgenic mouse model expressing a neprilysin variant with mutations at predicted DOPAL-binding cysteine residues crossed with 5xFAD mice. Compare these mice with standard 5xFAD mice following L-DOPA treatment to determine whether DOPAL-neprilysin interactions are necessary for L-DOPA's beneficial effects on Aβ pathology, neuroinflammation, and cognitive function.\n\nThis hypothesis provides a novel mechanistic framework that integrates dopamine metabolism with Aβ clearance pathways through a dual protective mechanism: direct inhibition of Aβ oligomerization and enhanced neprilysin-mediated degradation. This mechanism could help explain the observed protective effects of L-DOPA against Aβ pathology in neurodegenerative disease models and potentially guide the development of therapeutic strategies that target both aspects of Aβ processing."
  ],
  "dcterms:subject": [
    "amyloid beta",
    "amyloid clearance"
  ],
  "dcterms:source": [
    "DOPAL, a dopamine metabolite, decreases Aβ oligomerization in human neuroblastoma cells, reducing the cytotoxic effects of Aβ.",
    "The study shows that neprilysin acts as an Aβ-degrading enzyme, particularly affecting monomeric Aβ"
  ],
  "dcterms:abstract": [
    "Dopamine plays important roles in cognitive function and inflammation and therefore is involved in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD). Drugs that increase or maintain dopamine levels in the brain could be a therapeutic strategy for AD. However, the effects of dopamine and its precursor levodopa (L‑DOPA) on Aβ/tau pathology in vivo and the underlying molecular mechanisms have not been studied in detail. Here, we investigated whether L‑DOPA treatment alters neuroinflammation, Aβ pathology, and tau phosphorylation in 5xFAD mice, a model of AD. We found that L‑DOPA administration significantly reduced microgliosis and astrogliosis in 5xFAD mice. In addition, L‑DOPA treatment significantly decreased Aβ plaque number by upregulating NEP and ADAM17 levels in 5xFAD mice. However, L‑DOPA‑treated 5xFAD mice did not exhibit changes in tau hyperphos‑phorylation or tau kinase levels. These data suggest that L‑DOPA alleviates neuroinflammatory responses and Aβ pathology but not tau pathology in this mouse model of AD.",
    "[18F]AZD4694 is an amyloid beta (Aβ) imaging agent used in several observational studies and clinical trials. This study assessed 146 individuals evaluated with [18F]AZD4694 at baseline and a 2‐year follow‐up, revealing longitudinal patterns of Aβ accumulation. Results showed that cognitively unimpaired older adults displayed subtle Aβ accumulation, while Aβ positive cases exhibited greater increases, underscoring the agent’s potential to monitor Aβ levels in clinical settings.",
    "Our current understanding of the spread and neurodegenerative effects of tau neurofibrillary tangles (NFTs) within the medial temporal lobe (MTL) during the early stages of Alzheimer’s Disease (AD) is limited by the presence of confounding non-AD pathologies and the two-dimensional (2-D) nature of conventional histology studies. Here, we combine ex vivo MRI and serial histological imaging from 25 human MTL specimens to present a detailed, 3-D characterization of quantitative NFT burden measures.",
    "The direct access of olfactory afferents to memory-related cortical systems has inspired theories about the role of the olfactory pathways in the development of cortical neurodegeneration in Alzheimer’s disease (AD). This study used longitudinal PET imaging and diffusion MRI to investigate the spatiotemporal spreading and genetic vulnerabilities of AD-related pathology aggregates in the olfactory system. We find that odor identification deficits are associated with tau accumulation in key areas of the olfactory pathway, with strong predictive power for tau progression.",
    "Aging is a process accompanied by functional decline in tissues and organs with great social and medical consequences. Developing effective anti-aging strategies is of great significance. In this study, we demonstrated that transplantation of young hematopoietic stem cells (HSCs) into old mice can mitigate aging phenotypes, underscoring the crucial role of HSCs in the aging process.",
    "Accumulating senescent cells within tissues contribute to the progression of aging and age-related diseases. Botanical extracts, rich in phytoconstituents, present a useful resource for discovering therapies that could target senescence and thus improve healthspan. Here, we show that daily oral administration of a standardized extract of Salvia haenkei (Haenkenium) extended lifespan and healthspan of naturally aged mice. HK treatment inhibited age-induced inflammation, fibrosis and senescence markers across several tissues, as well as increased muscle strength and fur thickness compared with age-matched controls.",
    "Alzheimer’s disease (AD) is one of the world’s well-known neurodegenerative diseases, which is related to the balance mechanism of production and clearance of two proteins (amyloid-β and tau) regulated by the glymphatic system. Latest studies have found that AD patients exhibit impairments to their glymphatic system. However, the alterations in the AD disease continuum, especially in the early stages, remain unclear. Moreover, the relationship between the glymphatic system and cognitive dysfunction is still worth exploring.",
    "This study investigates the relationship between nuclear genetic variants and mitochondrial DNA (mtDNA) copy number and heteroplasmy in humans. Our analysis of whole-genome sequencing data across large cohorts reveals significant nuclear control over mtDNA traits, uncovering new insights into the genetic architecture that impacts mitochondrial dynamics and their implications for human health.",
    "Using single-cell whole-genome sequencing, we identified and characterized the landscape of somatic single-nucleotide variants (sSNVs) in single cardiomyocytes from individuals across the human lifespan. Aged cardiomyocytes were found to have a higher burden of sSNVs and show mutational signatures that suggest failed repair of oxidative DNA damage.",
    "Systemic amyloidosis is a progressive disorder characterized by the extracellular deposition of amyloid fibrils and accessory proteins in visceral organs and tissues. This study describes a prototypic pan-amyloid binding peptide-antibody fusion molecule that enhances macrophage uptake of amyloid.",
    "The transfer of mitochondrial DNA into the nuclear genomes of eukaryotes (Numts) has been linked to lifespan in nonhuman species and recently demonstrated to occur in rare instances from one human generation to the next. Here, we investigated numtogenesis dynamics in humans in 2 ways. First, we quantified Numts in 1,187 postmortem brain and blood samples from different individuals.",
    "Recently proposed biomarker-only diagnostic frameworks propose that amyloid-beta is necessary for placement on the Alzheimer’s disease continuum, whereas tau in the absence of amyloid-beta is considered to be a non-Alzheimer’s disease pathologic change. Similarly, the pathologic designation of tau in the absence of amyloid-beta is characterized as primary age-related tauopathy and separable from Alzheimer’s disease.",
    "Inclusion body myositis (IBM) is the most prevalent muscle disease in adults for which no current treatment exists. The pathogenesis remains poorly defined. This study explores the interplay between inflammation and mitochondrial dysfunction in IBM, demonstrating that the NLRP3 inflammasome is activated in muscle samples from IBM patients, alongside altered mitophagy. Findings suggest a vicious cycle driving muscle weakness in IBM.",
    "Age-related macular degeneration (AMD) is the leading cause of blindness among elderly people worldwide. However, there are currently no effective treatments for AMD. In this study, a polyethylene glycol (PEG)-coated rhodium nanozyme (PEG-RhZ) with excellent reactive oxygen species (ROS) and reactive nitrogen species (RNS) elimination capability was synthesized for the treatment of AMD.",
    "Cerebrospinal fluid (CSF) is responsible for maintaining brain homeostasis through nutrient delivery and waste removal for the central nervous system (CNS). Here, we demonstrate extensive CSF flow throughout the peripheral nervous system (PNS) by tracing distribution of multimodal 1.9-nanometer gold nanoparticles, roughly the size of CSF circulating proteins, infused within the lateral cerebral ventricle (a primary site of CSF production). CSF plays a consistent role in maintaining homeostasis throughout the nervous system with implications for CNS and PNS therapy and neural drug delivery.",
    "Pathological changes in the brain begin accumulating decades before the appearance of cognitive symptoms in Alzheimer’s disease. The deposition of amyloid beta proteins and other neurotoxic changes occur, leading to disruption in functional connections between brain networks. Discrete characterization of the changes that take place in preclinical Alzheimer’s disease has the potential to help treatment development by targeting the neuropathological mechanisms to prevent cognitive decline and dementia from occurring entirely.",
    "This trial evaluates the safety and efficacy of intra-articular injection of allogeneic adipose-derived mesenchymal stromal cells (AD-MSCs) for cartilage regeneration in patients with knee osteoarthritis (KOA) over 12 months, demonstrating significant clinical improvements and MRI findings.",
    "Aging affects iron homeostasis, as evidenced by tissue iron loading and anemia in the elderly. Iron needs in mammals are met primarily by iron recycling from senescent red blood cells (RBCs), chiefly accomplished by splenic red pulp macrophages (RPMs). Here, we found that 10-11-month-old female mice exhibit iron loading in RPMs, largely due to a drop in iron exporter ferroportin, which diminishes their erythrophagocytosis capacity and lysosomal activity. We further found that feeding mice an iron-reduced diet alleviates iron accumulation in RPMs and improves their function, thus demonstrating that dietary iron reduction can rejuvenate RPMs and enhance iron turnover efficacy."
  ]
}